She then turned the conversation to the subject of obesity, explaining that obesity triggers the inflammatory response. “To my mind, the best treatment is to deal with the obesity,” she says. Consequently, she believes that targeting one inflammatory molecule will not be enough to overcome the detrimental effect of obesity.
That said, she acknowledges that rheumatologists should be aware of the risk that the antiinflammatory drugs they prescribe may have an effect on diabetes. Patients with diabetes may be more prone to hypoglycemia when on antiinflammatory drugs and may require a modification of the dosage of their diabetes medicine.
Lara C. Pullen, PhD, is a medical writer based in the Chicago area.